Frontlight ResearchEarly access
Active, not recruitingNo phase
MiCLASP Post Market Clinical Follow-Up (PMCF) Study
Key facts
- Who runs it
- Edwards Lifesciences
- Where
- Austria, Germany, Greece, Italy, Netherlands, Poland, Spain, Switzerland, and United Kingdom36 sites in 9 countriesChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 1,000 people, planned
- Started
- 23 Aug 2019
- Expected to end
- 31 Mar 2031
- Type of study
- Observational
- Treatments tested
- Edwards PASCAL Transcatheter Valve Repair System and Edwards PASCAL Precision Transcatheter Valve Repair System
- Record updated
- 19 August 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Mitral TEER patients eligible per the current approved indication after Heart Team discussion and agreement
- Patient is willing and able to attend all follow-up visits and to perform all tests
- Provision of written informed consent
Who cannot take part
- Patients in ICU prior to the index procedure
- Patients are not eligible per the current Instructions for Use
- Non-elective or emergency TEER procedure for mitral regurgitation
This trial has no sites in United States.
It has sites in 9 countries. Choose a country to see its sites.
About the trial
What the trial wants to find out
This is a postmarket clinical follow up study on the safety and effectiveness of the Edwards PASCAL Transcatheter Valve Repair System and the Edwards PASCAL Precision Transcatheter Valve Repair System in transcatheter mitral valve repair.
Treatments tested
- Edwards PASCAL Transcatheter Valve Repair System and Edwards PASCAL Precision Transcatheter Valve Repair System
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Transcatheter Repair of Mitral Regurgitation With Edwards PASCAL Transcatheter Valve Repair System: A European Prospective, Multicenter Post Market Clinical Follow-Up (PMCF)
- Publications
- One-Year Outcomes of M-TEER With the PASCAL System in Atrial and Ventricular FMR: Insights From the MiCLASP Postmarket Clinical Follow-Up Study.Circulation. Cardiovascular interventions, 2026
- Mitral Valve Transcatheter Edge-to-Edge Repair: 1-Year Outcomes From the MiCLASP Study.JACC. Cardiovascular interventions, 2024
- Record updated
- 19 August 2026